Why Glaxosmithkline shares are a good investment right now, by manager of £600 million

Glaxosmithkline is showing the first signs of having turned a corner, and as the benefits of the present restructuring plan takes hold, the share price should benefit, Martin Todd, co-manager of the Hermes Sourcecap European Alpha Fund tells What Investment.